5.95
Neonc Technologies Holdings Inc Borsa (NTHI) Ultime notizie
NeOnc Technologies Reports Q4 2025 Results, Advances NEO100 & NEO212 Clinical Trials, and Secures $10M PIPE Financing - Minichart
NTHI 8-K & SEC Filings - Yahoo Finance Australia
NeOnc Technologies Reports Q4 Results and Trial Progress - TipRanks
NeOnc (Nasdaq: NTHI) details Q4 results, trial data and $10M PIPE - stocktitan.net
NeOnc Technologies Holdings, Inc. (NTHI) Stock Price, News, Quote & History - Yahoo Finance
NeOnc Technologies settles dispute with Fox Infused for $737,920.77 payment - Investing.com
Neonc Technologies Holdings Says Co May Offer Up To $300 Million Of Securities - TradingView
NeOnc (NASDAQ: NTHI) files $300M shelf to sell stock, debt and warrants - stocktitan.net
NeOnc Provides Business Update and Reports Q4 2025 Financial Results - Sahm
Brain cancer drug data in 5 months as NeOnc posts $62.1M Q4 loss - stocktitan.net
NTHI Should I Buy - Intellectia AI
NeOnc Technologies: Innovative Drug Delivery Platforms and Pipeline for Brain Cancer and CNS Disorders - Minichart
Neonc Technologies Holdings 10-K — Revenue $0.04M; EPS (3.20) - TradingView
NeOnc Technologies (NTHI) details NEO100, NEO212 trials and AI-driven CNS oncology platform in 2025 10-K - stocktitan.net
NeOnc Technologies Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Aug Opening: How do insiders feel about NeOnc Technologies Holdings IncMarket Sentiment Summary & Momentum Based Trading Signals - baoquankhu1.vn
Aug Swings: Can NeOnc Technologies Holdings Inc weather a recessionWeekly Trade Analysis & Community Trade Idea Sharing Platform - baoquankhu1.vn
Swing Trade: Is NeOnc Technologies Holdings Inc exposed to political riskPrice Action & High Accuracy Investment Signals - baoquankhu1.vn
Resistance Check: Is NeOnc Technologies Holdings Inc affected by consumer sentiment2026 Gainers & Stock Timing and Entry Methods - baoquankhu1.vn
Dip Buying: What are analysts price targets for NeOnc Technologies Holdings Inc2026 Earnings Impact & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
New to The Street Signs NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) to 12-Part National Broadcast Series Including T.V. Network Features, Earned Media, Commercials, and Iconic Outdoor Billboards - The Herald-Mail
NeOnc Announces New Private Placement to Support Liquidity - TipRanks
NeOnc Technologies Holdings, Inc. Signs Material Definitive Agreements for Securities Purchase and Warrants – SEC Filing Details - Minichart
NeOnc Technologies Launches Third Equity Round: Up to 545,583 Shares at $7.20, $1M First Close - tradingview.com
NeOnc Technologies (NASDAQ: NTHI) raises $1M in private stock and warrant deal - stocktitan.net
Breakouts Watch: What is the implied volatility of NeOnc Technologies Holdings Inc2026 Spike Watch & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
NeOnc Technologies Holdings, Inc. announced that it expects to receive $3.928198 million in funding - marketscreener.com
Neonc Technologies (NTHI) to Release Earnings on Friday - Defense World
Swing Trade: Will NeOnc Technologies Holdings Inc benefit from government policyTrade Exit Report & Fast Gain Swing Trade Alerts - baoquankhu1.vn
NeOnc Technologies Appoints David Choi as Chief Accounting Officer to Strengthen Financial Leadership Amid Clinical Expansion - Minichart
Trade Recap: Does NeOnc Technologies Holdings Inc have declining or rising EPSQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
NeOnc Technologies Appoints New Chief Accounting Officer - TipRanks
Neonc appoints David Choi as Chief Accounting Officer - TradingView
NeOnc Technologies appoints David Choi as chief accounting officer - Investing.com India
NeOnc Technologies appoints David Choi as chief accounting officer By Investing.com - au.investing.com
Neonc Technologies Stock Price Dips 0.1% - National Today
NeOnc Technologies Holdings, Inc. Appoints David Choi as Chief Accounting Officer - marketscreener.com
NeOnc Technologies Appoints David Choi as Chief Accounting Officer - GlobeNewswire
Latest NTHI NewsNeOnc Technologies Announces Near Completio... - stocktitan.net
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) - marketscreener.com
New brain cancer chemo targets blood-brain barrier as NeOnc adds $16M - stocktitan.net
Neonc Technologies (NASDAQ:NTHI) Trading Down 0.1% – Should You Sell? - Defense World
NeOnc sets Phase 2 dose for brain cancer drug NEO212 - Investing.com Nigeria
Surprises Report: Is NeOnc Technologies Holdings Inc. stock oversold or undervaluedPortfolio Return Report & Scalable Portfolio Growth Methods - Naître et grandir
NeOnc Reports Phase 1 NEO212 Results, Sets Phase 2 Dose - TipRanks
NeOnc Technologies Reports RP2D of 610 mg for Oral NEO212 after Phase 1 Dose-Escalation - TradingView
Breakouts Watch: Is NeOnc Technologies Holdings Inc affected by consumer sentiment2025 Trading Volume Trends & Verified Stock Trade Ideas - baoquankhu1.vn
Published on: 2026-03-05 20:09:42 - baoquankhu1.vn
NeOnc Technologies Settles Fox Infused Dispute With Payment - TipRanks
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET - Bitget
Earnings Risk: Will NeOnc Technologies Holdings Inc benefit from government policy2025 Earnings Surprises & Weekly Top Stock Performers List - baoquankhu1.vn
NeOnc sets Phase 2 dose for brain cancer drug NEO212 By Investing.com - Investing.com Canada
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):